Literature DB >> 11946663

Identification of the abnormal cholestatic lipoprotein (LP-X) in familial lecithin:Cholesterol acyltransferase deficiency.

Harald Torsvik1, Kåre Berg, Harry N. Magnani, Walter J. McConathy, Peter Alaupovic, Egil Gjone.   

Abstract

Entities:  

Year:  1972        PMID: 11946663     DOI: 10.1016/0014-5793(72)80758-0

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


× No keyword cloud information.
  11 in total

1.  Effect of lipoprotein-X on lipid metabolism in rat kidney.

Authors:  K O; M Ly; D Z Fang; J Frohlich; P C Choy
Journal:  Mol Cell Biochem       Date:  1997-08       Impact factor: 3.396

2.  Lipoproteins in lecithin-cholesterol-acyltransferase(LCAT)-deficiency. II. Further studies on the abnormal high-density-lipoproteins.

Authors:  G Utermann; H J Menzel; K H Langer; P Dieker
Journal:  Humangenetik       Date:  1975

3.  Plasma lipoprotein-X quantification on filipin-stained gels: monitoring recombinant LCAT treatment ex vivo.

Authors:  Lita A Freeman; Robert D Shamburek; Maureen L Sampson; Edward B Neufeld; Masaki Sato; Sotirios K Karathanasis; Alan T Remaley
Journal:  J Lipid Res       Date:  2019-02-26       Impact factor: 5.922

4.  LCAT Enzyme Replacement Therapy Reduces LpX and Improves Kidney Function in a Mouse Model of Familial LCAT Deficiency.

Authors:  Boris L Vaisman; Edward B Neufeld; Lita A Freeman; Scott M Gordon; Maureen L Sampson; Milton Pryor; Emily Hillman; Milton J Axley; Sotirios K Karathanasis; Alan T Remaley
Journal:  J Pharmacol Exp Ther       Date:  2018-12-18       Impact factor: 4.030

5.  Plasma lipoproteins in familial lecithin: cholesterol acyltransferase deficiency. Further studies of very low and low density lipoprotein abnormalities.

Authors:  J A Glomset; A V Nichols; K R Norum; W King; T Forte
Journal:  J Clin Invest       Date:  1973-05       Impact factor: 14.808

6.  Formation of lipoprotein-X. Its relationship to bile compounds.

Authors:  E Manzato; R Fellin; G Baggio; S Walch; W Neubeck; D Seidel
Journal:  J Clin Invest       Date:  1976-05       Impact factor: 14.808

7.  [Studies on the structure and metabolism of lipoprotein-X (LP-X), the abnormal plasmalipoprotein in cholestasis (author's transl)].

Authors:  D Seidel
Journal:  Klin Wochenschr       Date:  1977-07-01

8.  Management of lipoprotein X and its complications in a patient with primary sclerosing cholangitis.

Authors:  Eric J Brandt; Shane M Regnier; Edward Ky Leung; Sharon H Chou; Beverly W Baron; Helen S Te; Michael H Davidson; Robert M Sargis
Journal:  Clin Lipidol       Date:  2015-08-01

9.  Investigation of the abnormal low-density lipoproteins occurring in patients with obstructive jaundice.

Authors:  G M Kostner; P Laggner; H J Prexl; A Holasek
Journal:  Biochem J       Date:  1976-08-01       Impact factor: 3.857

Review 10.  Metabolism, energetics, and lipid biology in the podocyte - cellular cholesterol-mediated glomerular injury.

Authors:  Sandra Merscher; Christopher E Pedigo; Armando J Mendez
Journal:  Front Endocrinol (Lausanne)       Date:  2014-10-14       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.